The qCXL platform employs a customised treatment planning engine and real-time ultrasound monitoring for precision.

Editor’s note: This round‑up is based on press releases, peer‑reviewed publications, and company communications received in January and February 2026. All results are preliminary unless stated, and ...

Clinical trials can vary in length depending on several factors. Here's what you need to know about how long clinical trials last.

In reinstating human ADME to its portfolio, SGS strengths its ability to support drug development programmes with critical early clinical data. FANC approval enables SGS to reintroduce ¹⁴C human ADME ...

The MarketWatch News Department was not involved in the creation of this content. SINGAPORE, Jan. 20, 2026 /PRNewswire/ -- On January 9th, GENEIII reaffirmed its global leadership in ergothioneine ...

While there are shared principles across development programs, Barr noted that the nuances within immunology, ophthalmology, or chronic care studies can determine whether a trial succeeds or fails.

Sulforaphane is one of the most powerful phytochemicals identified in modern nutrition science. The clinical study ...

T Biosciences, an immunotherapy company changing the future of treatment for solid tumors and other immune-mediated diseases, ...

Strategic partnership eliminates human error and provides sponsors with real-time, high-quality clinical data for critical ...

TECLens treated the first patient in a first-in-human trial assessing safety and efficacy of qCXL-based refractive correction ...